PD-L1 differential expression among non-small cell lung cancer histologic subtypes and association with EGFR mutational status and ALK/ROS1 rearrangements

Carvalho S.; Lobo J.; Menezes D.; Lopes P.; Vieira R.; Rocha P.; Vieira J.; Teixeira M.; Henrique R.; Cunha A. L.

首页> 外文期刊>Virchows Archiv: an international journal of pathology >PD-L1 differential expression among non-small cell lung cancer histologic subtypes and association with EGFR mutational status and ALK/ROS1 rearrangements

【24h】

PD-L1 differential expression among non-small cell lung cancer histologic subtypes and association with EGFR mutational status and ALK/ROS1 rearrangements

机译：非小细胞肺癌组织学亚型的PD-L1差异表达及与EGFR突变状态和ALK / ROS1重排的关系

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

著录项
引文网络
相似文献
相关主题

著录项

来源
《Virchows Archiv: an international journal of pathology》 |2018年第1期|共1页
作者
Carvalho S.; Lobo J.; Menezes D.; Lopes P.; Vieira R.; Rocha P.; Vieira J.; Teixeira M.; Henrique R.; Cunha A. L.;
展开▼
作者单位

IPO Porto Pathol Porto Portugal;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类医学微生物学（病原细菌学、病原微生物学）;
关键词

相似文献

外文文献
中文文献
专利

1. PD-L1 differential expression among non-small cell lung cancer histologic subtypes and association with EGFR mutational status and ALK/ROS1 rearrangements [J] . Carvalho S., Lobo J., Menezes D., Virchows Archiv: an international journal of pathology . 2018,第Suppla1期

机译：非小细胞肺癌组织学亚型的PD-L1差异表达及与EGFR突变状态和ALK / ROS1重排的关系
2. Combined analysis of rearrangement of ALK, ROS1, somatic mutation of EGFR, KRAS, BRAF, PIK3CA, and mRNA expression of ERCC1, TYMS, RRM1, TUBB3, EGFR in patients with non-small cell lung cancer and their clinical significance [J] . Zhang Quan, Sun Tianyu, Kang Poming, Cancer chemotherapy and pharmacology. . 2016,第3期

机译：非小细胞肺癌患者ALK，ROS1重排，EGFR，KRAS，BRAF，PIK3CA体细胞突变以及ERCC1，TYMS，RRM1，TUBB3，EGFR mRNA表达的联合分析及其临床意义
3. Detecting EGFR mutations and ALK / ROS1 rearrangements in non-small cell lung cancer using malignant pleural effusion samples [J] . Yi Yao, Min Peng, Qinglin Shen, Thoracic cancer. . 2019,第2期

机译：使用恶性胸腔积液样品检测非小细胞肺癌中的EGFR突变和ALK / ROS1重排
4. Association between tumor heterogeneity and progression-free survival in non-small cell lung cancer patients with EGFR mutations undergoing tyrosine kinase inhibitors therapy [C] . Jiangdian Song, Di Dong, Yanqi Huang, Annual International Conference of the IEEE Engineering in Medicine and Biology Society . 2016

机译：接受酪氨酸激酶抑制剂治疗的EGFR突变非小细胞肺癌患者肿瘤异质性与无进展生存的关系
5. Regulation and Consequences of PD-L1 Expression in Non-Small Cell Lung Cancer [D] . Lastwika, Kristin J. 2014

机译：PD-L1表达在非小细胞肺癌中的调节及后果
6. Association between the histological subtype of lung adenocarcinoma EGFR/KRAS mutation status and the ALK rearrangement according to the novel IASLC/ATS/ERS classification [O] . YU-JIE DONG, YI-RAN CAI, LI-JUAN ZHOU, -1

机译：根据新型IASLC / ATS / ERS分类肺腺癌的组织学亚型EGFR / KRAS突变状态与ALK重排之间的关联
7. EGFR mutations and ROS1 and ALK rearrangements in a large series of non‐small cell lung cancer in South India [O] . Anil Tarigopula, Gayathri Ramasubban, Vani Chandrashekar, 2020

机译：EGFR突变和ROS1和ALK重排在南印度南部的大系列非小细胞肺癌中

PD-L1 differential expression among non-small cell lung cancer histologic subtypes and association with EGFR mutational status and ALK/ROS1 rearrangements

著录项

引文网络

相似文献

相关主题

期刊订阅